PROBIOTIX HEALTH LS-05 (X90) — Financial Flexibility Index
PROBIOTIX HEALTH LS-05 (X90) has a Financial Flexibility Index of -4.13x as of December 2024. Free cash flow of €-1.05 Million (operating CF €-1.06 Million minus capex €10.00K) represents -4% of total liabilities (€254.00K). Also explore how fast is PROBIOTIX HEALTH LS-05 growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PROBIOTIX HEALTH LS-05 Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for PROBIOTIX HEALTH LS-05 across 3 annual periods. See PROBIOTIX HEALTH LS-05 balance sheet independence to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for PROBIOTIX HEALTH LS-05 (2022–2024)
Year-by-year free cash flow to debt coverage for PROBIOTIX HEALTH LS-05. For the full company profile including market capitalisation, see X90 company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.13x | €-1.05 Million | €-1.06 Million | €254.00K | ▼ -1013.4% |
| 2023 | -0.37x | €-238.00K | €-238.00K | €641.00K | ▲ +78.0% |
| 2022 | -1.69x | €-591.94K | €-638.02K | €350.91K | — |